Matches in SemOpenAlex for { <https://semopenalex.org/work/W137185061> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W137185061 endingPage "257" @default.
- W137185061 startingPage "249" @default.
- W137185061 abstract "Intranasal corticosteroids are recommended as first-line therapy for the treatment of the symptoms of persistent allergic rhinitis (AR). Since the phase-out of chlorofluorocarbon nasal aerosols, intranasal corticosteroids have been available only as aqueous nasal sprays. This study was designed to assess the efficacy, safety, and quality-of-life benefits of beclomethasone dipropionate (BDP) hydrofluoroalkane nasal aerosol in subjects with perennial AR (PAR). After a 7- to 21-day placebo run-in period, eligible subjects aged ≥12 years with PAR were randomized to 6 weeks of once-daily treatment with BDP nasal aerosol at 320 μg or placebo. Reflective and instantaneous total nasal symptom scores (rTNSS and iTNSS, respectively), Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) score, and physician-assessed total nasal symptom score were evaluated. The primary end point was change from baseline in average morning (A.M.) and evening (P.M.) subject-reported rTNSS over the 6-week treatment period. Safety and tolerability were also assessed. Treatment with BDP nasal aerosol showed significantly greater improvement in average A.M. and P.M. rTNSS compared with placebo (mean treatment difference, -0.84; 95% confidence interval, -1.2, -0.5; p < 0.001). Greater improvements in rTNSS were reported as early as day 1 and were maintained throughout the 6-week treatment period with the exception of day 2. Greater improvements were seen for all four individual nasal symptoms (nasal congestion, nasal itching, rhinorrhea, and sneezing) with BDP nasal aerosol compared with placebo. Similarly, significant improvements were seen in average A.M. and P.M. iTNSS (p < 0.001) and RQLQ score (p = 0.001) with BDP nasal aerosol compared with placebo. In addition, BDP nasal aerosol treatment was well tolerated, and its safety profile was comparable to that of placebo. This clinical study indicated that treatment with BDP nasal aerosol provides statistically significant and clinically meaningful nasal symptom relief accompanied by improved quality of life in subjects with PAR. Additionally, treatment with BDP nasal aerosol was well tolerated with a safety profile comparable to that of placebo. This study was part of the clinical trial NCT01134705 registered in www.ClinicalTrials.gov." @default.
- W137185061 created "2016-06-24" @default.
- W137185061 creator A5003602195 @default.
- W137185061 creator A5028777703 @default.
- W137185061 creator A5041694829 @default.
- W137185061 creator A5055353022 @default.
- W137185061 creator A5082911997 @default.
- W137185061 creator A5088842944 @default.
- W137185061 date "2012-05-01" @default.
- W137185061 modified "2023-09-26" @default.
- W137185061 title "Safety and efficacy of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with perennial allergic rhinitis" @default.
- W137185061 doi "https://doi.org/10.2500/aap.2012.33.3571" @default.
- W137185061 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22737708" @default.
- W137185061 hasPublicationYear "2012" @default.
- W137185061 type Work @default.
- W137185061 sameAs 137185061 @default.
- W137185061 citedByCount "29" @default.
- W137185061 countsByYear W1371850612012 @default.
- W137185061 countsByYear W1371850612013 @default.
- W137185061 countsByYear W1371850612014 @default.
- W137185061 countsByYear W1371850612015 @default.
- W137185061 countsByYear W1371850612017 @default.
- W137185061 countsByYear W1371850612018 @default.
- W137185061 countsByYear W1371850612019 @default.
- W137185061 countsByYear W1371850612020 @default.
- W137185061 countsByYear W1371850612022 @default.
- W137185061 countsByYear W1371850612023 @default.
- W137185061 crossrefType "journal-article" @default.
- W137185061 hasAuthorship W137185061A5003602195 @default.
- W137185061 hasAuthorship W137185061A5028777703 @default.
- W137185061 hasAuthorship W137185061A5041694829 @default.
- W137185061 hasAuthorship W137185061A5055353022 @default.
- W137185061 hasAuthorship W137185061A5082911997 @default.
- W137185061 hasAuthorship W137185061A5088842944 @default.
- W137185061 hasConcept C121332964 @default.
- W137185061 hasConcept C126322002 @default.
- W137185061 hasConcept C1276947 @default.
- W137185061 hasConcept C141071460 @default.
- W137185061 hasConcept C142724271 @default.
- W137185061 hasConcept C19720800 @default.
- W137185061 hasConcept C197934379 @default.
- W137185061 hasConcept C204787440 @default.
- W137185061 hasConcept C27081682 @default.
- W137185061 hasConcept C2776178081 @default.
- W137185061 hasConcept C2776476923 @default.
- W137185061 hasConcept C2777714996 @default.
- W137185061 hasConcept C2777844070 @default.
- W137185061 hasConcept C2777992530 @default.
- W137185061 hasConcept C2778311950 @default.
- W137185061 hasConcept C2778375690 @default.
- W137185061 hasConcept C2779699568 @default.
- W137185061 hasConcept C2780973058 @default.
- W137185061 hasConcept C42219234 @default.
- W137185061 hasConcept C71924100 @default.
- W137185061 hasConcept C85663871 @default.
- W137185061 hasConcept C98274493 @default.
- W137185061 hasConceptScore W137185061C121332964 @default.
- W137185061 hasConceptScore W137185061C126322002 @default.
- W137185061 hasConceptScore W137185061C1276947 @default.
- W137185061 hasConceptScore W137185061C141071460 @default.
- W137185061 hasConceptScore W137185061C142724271 @default.
- W137185061 hasConceptScore W137185061C19720800 @default.
- W137185061 hasConceptScore W137185061C197934379 @default.
- W137185061 hasConceptScore W137185061C204787440 @default.
- W137185061 hasConceptScore W137185061C27081682 @default.
- W137185061 hasConceptScore W137185061C2776178081 @default.
- W137185061 hasConceptScore W137185061C2776476923 @default.
- W137185061 hasConceptScore W137185061C2777714996 @default.
- W137185061 hasConceptScore W137185061C2777844070 @default.
- W137185061 hasConceptScore W137185061C2777992530 @default.
- W137185061 hasConceptScore W137185061C2778311950 @default.
- W137185061 hasConceptScore W137185061C2778375690 @default.
- W137185061 hasConceptScore W137185061C2779699568 @default.
- W137185061 hasConceptScore W137185061C2780973058 @default.
- W137185061 hasConceptScore W137185061C42219234 @default.
- W137185061 hasConceptScore W137185061C71924100 @default.
- W137185061 hasConceptScore W137185061C85663871 @default.
- W137185061 hasConceptScore W137185061C98274493 @default.
- W137185061 hasIssue "3" @default.
- W137185061 hasLocation W1371850611 @default.
- W137185061 hasLocation W1371850612 @default.
- W137185061 hasOpenAccess W137185061 @default.
- W137185061 hasPrimaryLocation W1371850611 @default.
- W137185061 hasRelatedWork W114379940 @default.
- W137185061 hasRelatedWork W1597532427 @default.
- W137185061 hasRelatedWork W1821286858 @default.
- W137185061 hasRelatedWork W1968412591 @default.
- W137185061 hasRelatedWork W2005846628 @default.
- W137185061 hasRelatedWork W2047834036 @default.
- W137185061 hasRelatedWork W2072495699 @default.
- W137185061 hasRelatedWork W2110067748 @default.
- W137185061 hasRelatedWork W2139119447 @default.
- W137185061 hasRelatedWork W1061128349 @default.
- W137185061 hasVolume "33" @default.
- W137185061 isParatext "false" @default.
- W137185061 isRetracted "false" @default.
- W137185061 magId "137185061" @default.
- W137185061 workType "article" @default.